• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
39.9450037
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
10.83
33.47
EPS(TTM)
Face Value()
Div & Yield %
3.6
10
0
 

Urja Global consolidated net profit rises 66.67% in the March 2026 quarter
May 22,2026
Net profit of Urja Global rose 66.67% to Rs 0.20 crore in the quarter ended March 2026 as against Rs 0.12 crore during the previous quarter ended March 2025. Sales rose 2.33% to Rs 17.58 crore in the quarter ended March 2026 as against Rs 17.18 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.51% to Rs 1.34 crore in the year ended March 2026 as against Rs 1.27 crore during the previous year ended March 2025. Sales declined 0.82% to Rs 66.70 crore in the year ended March 2026 as against Rs 67.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales17.5817.18 2 66.7067.25 -1
OPM %2.674.13 -3.192.66 -
PBDT0.470.92 -49 2.482.41 3
PBT0.360.81 -56 1.992.03 -2
NP0.200.12 67 1.341.27 6